RedBrick AI vs Armilla AI
Side-by-side comparison of AI visibility scores, market position, and capabilities
Medical imaging annotation platform accelerating AI training data creation by 60%; $5.1M from Peak XV and YC serving hospitals and healthcare AI companies for FDA-cleared model development.
About
RedBrick AI is a healthcare AI platform specializing in medical imaging annotation — providing the configurable workflow system, annotation tools, and quality management features that hospitals, research institutions, and healthcare AI companies need to create high-quality training datasets for medical AI models. Founded in 2021 and backed by Peak XV Partners (formerly Sequoia Capital India) and Y Combinator with $5.1 million raised, RedBrick AI serves customers training AI models on CT scans, MRI, X-rays, and ultrasound images, accelerating annotation workflows by up to 60%.\n\nRedBrick AI's platform provides specialized annotation tools for 3D medical imaging (segmentation brushes for 3D volumes, DICOM viewer integration, measurement tools), configurable review workflows (managing the multi-step annotation, verification, and adjudication process required for medical-grade data quality), and active learning integration (prioritizing the most informative cases for human annotation to maximize model improvement per annotation hour). The platform handles the regulatory documentation requirements for medical AI development, including audit trails that support FDA submission.\n\nIn 2025, RedBrick AI competes in the medical AI training data and annotation market with Scale AI (general-purpose data annotation), Appen, CVAT (open-source), and specialized medical annotation platforms like MD.ai for medical image annotation tools. The healthcare AI market is growing rapidly as FDA-cleared AI diagnostic tools proliferate — each new radiology AI model requires thousands of annotated images for training, and the quality of annotations directly affects model safety. RedBrick AI's medical-specific tooling (3D annotation, DICOM handling, clinical workflow) provides depth that general annotation platforms lack. The 2025 strategy focuses on growing with hospital systems building internal AI capabilities, deepening regulatory compliance documentation, and expanding from imaging to other medical data modalities (pathology slides, clinical notes).
AI quality assurance with insurance-backed warranties from Swiss Re and Greenlight Re; EU AI Act compliance assessments backed by YC and reinsurance partners for high-risk AI deployments.
About
Armilla AI is a third-party AI quality assurance and warranty company that evaluates AI models for organizations deploying AI in regulated or high-stakes contexts — assessing models against EU AI Act and NIST AI Risk Management Framework requirements for risks including bias, hallucination, robustness failures, and adversarial vulnerabilities, then providing performance guarantees backed by insurance coverage from reinsurers Swiss Re, Greenlight Re, and Chaucer. Founded in Toronto, Canada, Armilla raised $6.81 million total including a C$4.5 million seed round in February 2024 from Mistral Venture Partners, MS&AD Ventures, Y Combinator, and its reinsurance partners.\n\nArmilla's model is unique in the AI governance market — rather than just providing compliance reports, Armilla backs its assessments with insurance warranty products. An enterprise deploying a third-party AI model can purchase an Armilla warranty that pays out if the model performs differently than assessed (fails on bias, accuracy, or robustness metrics), transferring AI performance risk to insurance markets that can price and distribute it. This insurance mechanism creates financial accountability for AI quality claims that audit reports alone don't provide.\n\nIn 2025, Armilla competes in the AI governance, risk, and compliance market with Credo AI, Arthur AI, and AI audit firms for enterprise AI risk assessment and compliance tools. The EU AI Act, fully applicable by August 2025 for high-risk AI systems, is driving enterprise compliance urgency — companies deploying AI in hiring, credit scoring, healthcare, and other regulated contexts need third-party conformity assessments. Armilla's insurance-backed warranty differentiates its offering from pure advisory competitors. The reinsurer backing (Swiss Re, Greenlight Re, Chaucer) provides both capital credibility and distribution through insurance broker channels. The 2025 strategy focuses on growing EU AI Act compliance assessments and expanding the warranty product coverage to more AI deployment use cases.
AI Visibility Head-to-Head
Also Compare
RedBrick AI vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.